rethinkPeptides Search
Menu
Research citation

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.

Diabetes care, 39(10), 1693-701

Citation

Ahrén, Bo; Hirsch, Irl B; Pieber, Thomas R; Mathieu, Chantal; Gómez-Peralta, Fernando; Hansen, Troels Krarup; Philotheou, Areti; Birch, Sune; Christiansen, Erik; Jensen, Thomas Jon; Buse, John B. (2016). Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.. Diabetes care, 39(10), 1693-701. https://doi.org/10.2337/dc16-0690